Literature DB >> 32744977

Regulatory Role of Chinese Herbal Medicine in Regulated Neuronal Death.

Xiuyu Wu1, Ximin Hu2, Qi Zhang1, Fengxia Liu3, Kun Xiong1.   

Abstract

Ischemic neuronal injury results from a complex series of pathophysiological events, including oxidative, excitotoxicity, inflammation and nitrative stress. Consequently, many of these events can induce cell death, including necrosis (unregulated cell death) and apoptosis (a type of regulated cell death). These are long-established paradigms to which newly discovered regulated cell death processes have been added, such as necroptosis (a regulated form of necrosis) and autophagydependent cell death. Moreover, many researchers have targeted products associated with Chinese herbal medicine at regulated pathways for the treatment of ischemic neuronal injury. In East Asia, these drugs have been known for centuries to protect and improve the nervous system. Herbal extracts, especially those used in Chinese herbal medicine, have emerged as new pharmaceuticals for the treatment of ischemic neuronal injury. Here, we review the evidence from preclinical studies investigating the neuroprotective properties and therapeutic application of Chinese herbal medicines (Chinese herbal monomer, extract, and medicinal compounds) and highlight the potential mechanisms underlying their therapeutic effects via targeting differently regulated cell death pathways. Notably, many herbs have been shown to target multiple mechanisms of regulated cell death and, in combination, may exert synergistic effects on signaling pathways, thereby attenuating multiple aspects of ischemic pathology. In this review, we summarize a generally regulated pathway of cell death as a target for novel natural herbal regimens against ischemic neuronal injury. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chinese herbal medicine; Ischemic; injury; neuronal; paradigm.; regulated cell death

Mesh:

Substances:

Year:  2021        PMID: 32744977     DOI: 10.2174/1871527319666200730165011

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

Review 1.  Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases.

Authors:  Qi Zhang; Xin-Xing Wan; Xi-Min Hu; Wen-Juan Zhao; Xiao-Xia Ban; Yan-Xia Huang; Wei-Tao Yan; Kun Xiong
Journal:  Front Cell Dev Biol       Date:  2021-12-16

2.  Oral administration of East Asian herbal medicine for peripheral neuropathy: A protocol for systematic review and meta-analysis with using association rule analysis to identify core herb pattern.

Authors:  Hoseok Lee; Hee-Geun Jo; Donghun Lee
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

3.  PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons.

Authors:  Wei-Tao Yan; Wen-Juan Zhao; Xi-Min Hu; Xiao-Xia Ban; Wen-Ya Ning; Hao Wan; Qi Zhang; Kun Xiong
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

4.  Detoxification technology and mechanism of processing with Angelicae sinensis radix in reducing the hepatotoxicity induced by rhizoma Dioscoreae bulbiferae in vivo.

Authors:  Lingling Song; Junming Wang; Mingzhu Gong; Yueyue Zhang; Yamin Li; Xiaohui Wu; Lingyu Qin; Yaqian Duan
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

5.  The Role of HSP90α in Methamphetamine/Hyperthermia-Induced Necroptosis in Rat Striatal Neurons.

Authors:  Lv-Shuang Liao; Shuang Lu; Wei-Tao Yan; Shu-Chao Wang; Li-Min Guo; Yan-di Yang; Kai Huang; Xi-Min Hu; Qi Zhang; Jie Yan; Kun Xiong
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.